Oura Files Confidentially for US IPO as Smart Ring Health Platform Targets $2 Billion Revenue
Key Insights
Oura (search), the smart ring health technology company, has confidentially filed for a US IPO with Goldman Sachs (search) and other major banks leading the offering targeted for later this year.
The company reported revenue above $500 million in 2024 and is on track for approximately $1 billion in 2025 sales, with projections reaching $1.5-2 billion by 2026.
Oura (search) has evolved from sleep tracking to comprehensive health monitoring including stress, cardiovascular load, and women's health, serving over 5.5 million users with a $5.99 monthly subscription model.
Oura (search), the Finnish-founded smart ring manufacturer, has confidentially filed a draft IPO prospectus with the Securities and Exchange Commission, positioning itself as a leading health technology platform with concrete revenue growth and a dominant market position in the emerging smart ring category.
Strong Financial Performance Drives IPO Timing
The company has assembled a high-profile underwriting syndicate including Goldman Sachs (search), Morgan Stanley (search), JPMorgan (search), Allen & Co, and Jefferies to manage the public offering, targeting a listing later this year. Oura (search) reported revenue exceeding $500 million in 2024, with CEO Tom Hale indicating the company is on track for approximately $1 billion in 2025 sales.
The growth trajectory appears robust, with official 2026 outlook projections around $1.5 billion and upper-case scenarios approaching $2 billion in revenue. This represents a doubling of revenue from 2024 to 2025, demonstrating the accelerating adoption of health-focused wearable technology.
Market Leadership in Smart Ring Category
Oura (search)'s market position is strengthened by its early entry and continued dominance in the smart ring segment. The company has sold over 5.5 million Oura Rings since launch, with half of these units shipping in the past twelve months alone. This acceleration indicates growing consumer acceptance of ring-form health monitoring devices.
The company maintains its leadership position despite emerging competition from Samsung (search)'s Galaxy Ring, Ultrahuman (search)'s Ring Air, and rumored Apple (search) ring development. According to the company's assessment, these competitors have "chipped at the category rather than redefined it," allowing Oura (search) to retain the bulk of global smart-ring sales.
Platform Evolution Beyond Sleep Tracking
Originally launched in 2015 as a sleep tracking device, Oura (search) has expanded its capabilities to encompass comprehensive health monitoring. The platform now includes stress monitoring, cardiovascular load assessment, women's health tracking, and recently added gesture input functionality following the acquisition of UK micro-gesture startup Doublepoint (search).
The company is on track to surpass five million paid members this quarter, representing a fourfold increase over the past two years. This subscriber growth supports the recurring revenue model built around a $5.99 monthly subscription service that provides health analytics and insights.
Partnerships and Market Positioning
Oura (search) has established partnerships with more than 1,200 health, wellness, and commercial brands and organizations, including high-profile collaborations with Team USA and U.S. Soccer. These partnerships demonstrate the platform's credibility in professional sports and wellness applications.
The company recently relocated its headquarters from Finland to San Francisco, signaling its commitment to the US market and proximity to technology and investment communities.
Competitive Landscape and Market Risks
The broader health-focused wearables market continues to expand, with established players like Apple (search) adding health features to the Apple Watch and Garmin (search) reporting 42% increases in fitness product revenue. Competitor Whoop (search) raised $575 million at a $10.1 billion valuation in March, while Google (search) announced new screenless Fitbit devices with advanced health insights.
Potential challenges include FDA regulatory reviews for health data applications, insurance reimbursement decisions, and competitive pricing pressure on the subscription model. Apple (search)'s platform leverage presents a particular risk, as the company could potentially integrate ring-style sensing into existing devices or develop competing products.
Valuation and Investment Context
Oura (search)'s October Series E funding round, led by Fidelity (search) with participation from ICONIQ, Whale Rock, and Atreides, valued the company at $11 billion. The company has raised more than $1.5 billion in total funding across multiple rounds.
The IPO filing comes during a period of renewed activity in public markets, with the IPO market expected to strengthen driven by AI-focused companies and high-profile offerings. According to Renaissance Capital, $28.9 billion has been raised this year across IPOs above the $50 million market cap range, representing a 146% increase over the previous year.
CEO Tom Hale emphasized the company's evolution in a recent statement: "We've evolved beyond tracking to deliver actionable health intelligence that helps people better understand their bodies and make more informed decisions for their long-term health."